Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

NCT03192215 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03192215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03192215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Lead sponsor
Columbia University
Phase
Phase 3
Overall status
Terminated
Start date
January 19, 2018
Completion date
April 17, 2023
Enrollment
1,015 (actual)
Sites
177

Conditions

As the registry lists them; a condition with its own page is linked.

stroke